<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="case-report" xml:lang="en" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">Eye (Lond)</journal-id><journal-id journal-id-type="iso-abbrev">Eye (Lond)</journal-id><journal-id journal-id-type="pmc-domain-id">1476</journal-id><journal-id journal-id-type="pmc-domain">eye</journal-id><journal-title-group><journal-title>Eye</journal-title></journal-title-group><issn pub-type="ppub">0950-222X</issn><issn pub-type="epub">1476-5454</issn><publisher><publisher-name>Nature Publishing Group</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC3496104</article-id><article-id pub-id-type="pmcid-ver">PMC3496104.1</article-id><article-id pub-id-type="pmcaid">3496104</article-id><article-id pub-id-type="pmcaiid">3496104</article-id><article-id pub-id-type="pmid">23079752</article-id><article-id pub-id-type="doi">10.1038/eye.2012.191</article-id><article-id pub-id-type="pii">eye2012191</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Case Series</subject></subj-group></article-categories><title-group><article-title>Adverse ophthalmic reaction in poppers users: case series of &#8216;poppers maculopathy'</article-title><alt-title alt-title-type="running">Poppers maculopathy</alt-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Davies</surname><given-names initials="AJ">A J</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="caf1">*</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Kelly</surname><given-names initials="SP">S P</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Naylor</surname><given-names initials="SG">S G</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Bhatt</surname><given-names initials="PR">P R</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Mathews</surname><given-names initials="JP">J P</given-names></name><xref ref-type="aff" rid="aff3">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Sahni</surname><given-names initials="J">J</given-names></name><xref ref-type="aff" rid="aff4">4</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Haslett</surname><given-names initials="R">R</given-names></name><xref ref-type="aff" rid="aff3">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>McKibbin</surname><given-names initials="M">M</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib><aff id="aff1"><label>1</label><institution>Department of Ophthalmology, Royal Bolton Hospital</institution>, Bolton, <country>UK</country></aff><aff id="aff2"><label>2</label><institution>Department of Ophthalmology, St James's University Hospital</institution>, Leeds, <country>UK</country></aff><aff id="aff3"><label>3</label><institution>The Stanley Eye Unit, Abergele Hospital, Betsi Cadwaladr University Health Board</institution>, <country>North Wales, UK</country></aff><aff id="aff4"><label>4</label><institution>Department of Ophthalmology, Liverpool and Broadgreen University Hospitals NHS Trust</institution>, Liverpool, <country>UK</country></aff></contrib-group><author-notes><corresp id="caf1"><label>*</label><institution>Department of Ophthalmology, Royal Bolton Hospital</institution>, Minerva Road, Farnworth, Bolton BL4 0JR, <country>UK</country></corresp></author-notes><pub-date pub-type="ppub"><month>11</month><year>2012</year></pub-date><pub-date pub-type="epub"><day>19</day><month>10</month><year>2012</year></pub-date><volume>26</volume><issue>11</issue><issue-id pub-id-type="pmc-issue-id">216308</issue-id><fpage>1479</fpage><lpage>1486</lpage><history><date date-type="received"><day>23</day><month>03</month><year>2012</year></date><date date-type="accepted"><day>01</day><month>06</month><year>2012</year></date></history><pub-history><event event-type="pmc-release"><date><day>01</day><month>11</month><year>2013</year></date></event><event event-type="pmc-live"><date><day>01</day><month>11</month><year>2013</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2013-11-01 00:14:39.657"><day>01</day><month>11</month><year>2013</year></date></event></pub-history><permissions><copyright-statement>Copyright &#169; 2012 Royal College of Ophthalmologists</copyright-statement><copyright-year>2012</copyright-year><copyright-holder>Royal College of Ophthalmologists</copyright-holder></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="eye2012191a.pdf"/><abstract><sec><title>Background</title><p>Poppers are a recreational substance of abuse belonging to the alkyl nitrite family of compounds. In the United Kingdom, where they are legal to purchase but illegal to sell for human consumption, 10% of the general population have tried them. They are considered low risk to physical and mental health. Two recent case series from France demonstrated foveal pathology in individuals associated with poppers use.</p></sec><sec sec-type="methods"><title>Method</title><p>A case series of seven patients presenting to four hospitals in the United Kingdom with visual impairment and maculopathy associated with inhalation of poppers.</p></sec><sec sec-type="results"><title>Results</title><p>All patients experienced visual symptoms associated with poppers use. The majority had impaired visual acuity, central scotomata, distortion, or phosphenes. Clinical signs on fundoscopy ranged from normal foveal appearance to yellow, dome-shaped lesions at the foveola. Spectral domain optical coherence tomography (SD-OCT) showed varying degrees of disruption of the presumed inner segment/outer segment (IS/OS) junction.</p></sec><sec sec-type="discussion"><title>Discussion</title><p>Although poppers have been in use for several decades, in 2007, following legislative changes, there was a change in the most commonly used compound from isobutyl nitrite to isopropyl nitrite. There were no reports of &#8216;poppers maculopathy' before this. Poppers maculopathy may be missed if patients are not directly questioned about their use. The disruption or loss of the presumed IS/OS junction on SD-OCT are a characteristic feature. Further study of maculopathy in poppers users is now needed. Raising public awareness of the ocular risks associated with their use may be necessary.</p></sec></abstract><kwd-group><kwd>poppers</kwd><kwd>maculopathy</kwd><kwd>isopropyl</kwd><kwd>isobutyl</kwd><kwd>nitrite</kwd><kwd>retina</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>